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a  b  s  t  r  a  c  t
-Cypermethrin  is  a widely  used  insecticide  and, at high  doses,  induces  oxidative  stress
in mammals.  Curcumin  is  an  antioxidant  phytochemical  commonly  used  for food  color-
ing and  ﬂavoring.  We  aimed  to  investigate  the  effects  of  continuous  dietary  exposure  to
low doses of -cypermethrin,  as  is the  case  in  exposed  humans,  on  oxidative  stress  and
its potential  prevention  by dietary  curcumin.  Four  groups  of  ten male  Wistar  rats  were
ad libitum-fed  a control  diet  or identical  diets  fortiﬁed  with  -cypermethrin  (350  mg/kg
diet),  curcumin  (1000  mg/kg  diet),  or -cypermethrin  and  curcumin  (350  and  1000  mg/kg
diet, respectively)  for 7  weeks.  -Cypermethrin  accumulated  in  adipose  tissues  and  was
detectable  in  kidney,  liver,  and  brains.  Dietary  -cypermethrin  did  not  alter  concentrations
of  malondialdehyde,  ascorbic  and  uric  acid,  retinol,  liver  damage  markers,  or the  activities
of CAT  and  SOD,  but reduced  vitamin  E in  blood.  -Cypermethrin  did not  affect  malon-
dialdehyde  or  reduced  glutathione  concentrations  in any  of  the  tissues,  but  signiﬁcantlyRats increased  glutathione  disulﬁde  in  kidney  and  subcutaneous  adipose  tissue.  In conclusion,
dietary  exposure  to small  doses  of  -cypermethrin  did  not  induce  oxidative  stress  in  rats
and may  be  less  toxic  than  exposure  to  comparable  quantities  administered  as  single  high
doses  by gastric  intubation.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe CC  BAbbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase;
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malondialdehyde; SOD, superoxide dismutase.
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1. Introduction
Cypermethrin is a type II synthetic pyrethroid that
is  widely used as pest control in agriculture, forestry,
horticulture, health programs, and private homes. Cyper-
methrin is a racemic mixture of eight stereoisomers of
which  four exist in cis- and four in trans-conﬁguration.
Two of the cis-isomers, namely the 1R,cis- and 1S,cis-
stereoisomers make up -cypermethrin, the most active
pair  of the cypermethrin isomers [4,7]. The urinary con-
centrations of 3-phenoxybenzoic acid, a cypermethrin
metabolite, were positively correlated with the frequency
 access article under the CC BY-NC-ND license
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f spraying in Japanese pest control operators [20]. Because
f  its widespread use, not only persons working with insec-
icides,  but large parts of the population are regularly
xposed to cypermethrin. Cypermethrin metabolites were
ound  in 60% of the collected urine samples in a German
opulation [15] and in >70% of urine samples in a popu-
ation  in the USA [1]. Ingestion of cypermethrin with the
iet  was identiﬁed as the most likely route of exposure in
ermany  [33].
In  rats, oral gavage of single or repeated doses of cyper-
ethrin induces oxidative stress and subsequent oxidative
amage in erythrocytes, brain, and liver [9,13,17,32] and is
ccompanied by reductions in the activities of the antiox-
dant  enzymes catalase [9,32] and superoxide dismutase
9]. In these studies, simultaneous treatment with antiox-
dants,  such as vitamin E, phytochemicals from propolis,
r  curcumin, reduced cypermethrin-induced oxidative
tress and increased the activities of antioxidant enzymes
9,13,17,32].
Curcumin is a yellow pigment and lipophilic phenolic
ompound derived from the rhizome of the plant turmeric
Curcuma longa of the ginger family (Zingiberaceae)) and is
sed  for food coloring and ﬂavoring in private homes and
y  the food industry. Among the reported health beneﬁcial
ffects of dietary curcumin are its potent antioxidant and
nti-inﬂammatory activities [2].
Previous animal studies have applied single or repeated
oses of cypermethrin, equivalent to 10% LD50 or higher,
issolved in oil via gastric intubation [9,12,32], which
ould represent the rather unrealistic scenario of a high-
ose  oral exposure once a day in humans. The present
xperiment was therefore designed to mimic  a constant
ow-level dietary exposure spread out over the day, which
s  a more realistic simulation of the exposure pattern
bserved in humans [33]. The aim of this experiment was
o  test whether or not this continuous dietary exposure
o small doses of -cypermethrin would induce oxidative
tress in rats and, if so, whether or not simultaneous inges-
ion  of curcumin would reduce pesticide-induced oxidative
able 1
eed  intake,a body and organ weights of rats fed control diets or identical diets su
r  a mixture of -cypermethrin and curcumin (350 and 1000 mg/kg, respectively
Control -Cypermethrin 
Feed intake (g/rat/day)a
Day 0–14 20.9 ± 4.5 20.0 ± 1.1 
Day 15–28 26.6 ± 0.9 25.5 ± 1.4 
Day 29–49 34.9 ± 1.1 34.4 ± 1.7 
Day 1–49 28.7 ± 1.7 27.9 ± 0.8 
Body weight (g)
Day  0 240.1 ± 21.0 245.5 ± 17.9 
Day 14 348.5 ± 21.1 340.4 ± 25.6 
Day 28 418.4 ± 33.2 405.8 ± 32.2 
Day 49 462.7 ± 37.8 459.7 ± 36.2 
Organ weight (g)
Liver  12.2 ± 1.3 13.2 ± 1.7 
Kidney 3.3 ± 0.3 3.5 ± 0.4 
Brain 2.1 ± 0.1 2.1 ± 0.2 
Heart 1.7 ± 0.2 1.7 ± 0.2 
Lung 2.1 ± 0.3 2.1 ± 0.2 
a Feed intake per rat was  calculated by dividing the daily feed consumption of a
cages  per group).ports 1 (2014) 1106–1114 1107
damage.  As previous studies focused on acute effects
shortly after high-dose exposure, we  furthermore aimed
to  investigate the potential accumulation of pyrethroid-
induced oxidative damage over a longer period of seven
weeks.
2.  Methods
2.1. Chemicals
-Cypermethrin (CAS # 52315-07-8; purity ≥97%) was
a  kind gift from Nanjing Essence Fine-Chemical Co., Ltd.
(Nanjing, China). Curcumin (LKT-C8069; CAS # 458-37-7;
purity >90%) was from LKT Laboratories Inc. (St. Paul, MN,
USA).  Malondialdehyde bis (diethyl acetal) was from Merck
KGaA  (Darmstadt, Germany); 2,4-dinitrophenylhydrazine
(DNPH), catalase (CAT; product no. C30), Red cell lysing
Buffer Hybri-MaxTM (product no. R7757), potassium perio-
date,  iodonitrotetrazolium chloride, superoxide dismutase
from  bovine erythrocytes, xanthine, xanthine oxidase, and
Purpald® were from Sigma–Aldrich Chemie GmbH (Stein-
heim, Germany). Hydrogen peroxide solution (35%) was
purchased from Carl Roth GmbH + Co. KG (Karlsruhe,
Germany).
2.2. Experimental animals and diets
The animal experiment was  performed in accordance
with the guidelines for the care and use of animals for
experimental procedures and approved by the Regional
Council of Stuttgart, Germany. Forty male Wistar rats
(200–250 g; Janvier, Le Genest Saint-Isle, France) were
used because male rats, contrary to female rats, can be
housed in groups and randomized into groups of ten ani-
mals  with similar mean body weights (Table 1) and kept in
groups  of 3–4 animals per cage under standard conditions
(22 ± 2 ◦C, 55 ± 5% relative humidity, 12 h light/dark cycle).
Cages  (type IV) were equipped with softwood bedding, a
pplemented with -cypermethrin (350 mg/kg), curcumin (1000 mg/kg),
) for seven weeks.
Curcumin -Cypermethrin
+ Curcumin
P
24.0 ± 1.7 20.1 ± 1.1 0.255
25.1 ± 4.7 24.7 ± 0.1 0.812
39.3 ± 6.2 33.4 ± 1.1 0.209
31.2 ± 2.6 27.3 ± 0.8 0.087
247.7 ± 20.5 240.5 ± 13.0 0.743
355.4 ± 15.4 337.2 ± 21.5 0.230
433.7 ± 19.3 403.4 ± 31.5 0.104
483.9 ± 26.4 448.5 ± 42.7 0.193
13.3 ± 0.8 12.7 ± 1.6 0.271
3.4 ± 0.3 3.2 ± 0.4 0.199
2.1 ± 0.1 2.2 ± 0.1 0.697
1.8 ± 0.2 1.6 ± 0.2 0.244
2.3 ± 0.2 2.1 ± 0.1 0.258
ll animals in a cage by the number of animals in the respective cage; n = 3
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water bottle, and a plastic tube. Animals were fed a mod-
iﬁed  standard rodent diet (C1000; modiﬁcations: vitamin
A,  2500 IU; vitamin E, 30 mg;  selenium, 150 g; all values
per  kg diet; Altromin Spezialfutter GmbH & Co. KG, Lage,
Germany) that was free from synthetic antioxidants, plant
polyphenols, and ascorbic acid for an acclimation period of
one  week and then assigned to one of four treatments: (1)
the  control group received the standard diet only, (2) the
cypermethrin group received the standard diet fortiﬁed
with 350 mg/kg -cypermethrin, (3) the curcumin group
the  standard diet fortiﬁed with 1000 mg/kg curcumin, and
(4)  the cypermethrin + curcumin group the standard diet
fortiﬁed  with a combination of 350 mg/kg -cypermethrin
and 1000 mg/kg curcumin. Animals had free access to
water  and feed during the entire experiment, which lasted
7  weeks. Blood was collected from the jugular vein into
separate K-heparinized tubes after CO2 anesthesia and
decapitation. Blood samples were centrifuged (3000 × g,
10  min) to obtain plasma and both whole blood and plasma
samples were stored at −80 ◦C until analyzed.
2.3. Quantiﬁcation of malondialdehyde in whole blood
and  tissues
Malondialdehyde (MDA) in whole blood and tissues was
analyzed according a method described by [25]. Brieﬂy,
whole blood or homogenates of liver, kidney, brain and
fat  (25 L) mixed with 1% sulphuric acid (75 L) and
6 M NaOH solution (20 L) were incubated at 60 ◦C for
30  min  (waterbath). After de-proteinisation with 25% per-
chloric  acid (50 L) supernatant (100 L) was mixed with
5  mM 2,4-dinitrophenyl-hydrazine (10 L) and incubated
for  30 min  before analysis on a Shimadzu Prominence HPLC.
The  MDA-2,4-dinitrophenyl-hydrazine adduct was  sepa-
rated  on a Reprosil-Pur 120 C18 AQ (250 mm × 4.6 mm,
5  m;  Trentec) with 50% methanol in formic acid buffer
(0.05 M,  pH 3.75) at 1 mL/min and detected by UV–vis at
310  nm.  Pooled whole blood (n = 7) analyzed along with
the  samples gave intra-batch and inter-batch coefﬁcients
of  variation of 2.4% and 3.1%, respectively.
2.4. Liver enzymes and lipids in plasma
Aspartate aminotransferase (AST), alanine transami-
nase (ALT), and alkaline phosphatase (ALP) were measured
in  plasma using diagnostic kits (OSR6009, 6007, and 6004,
respectively; Beckman Coulter) adapted for the Olympus
AT200 auto analyser. Plasma cholesterol and triacylgly-
cerols were determined using diagnostic kits OSR6116,
61118, and OE66300 (Beckman Coulter).
2.5. Quantiﬁcation of lipid-soluble vitamins in plasma
and tissues
Retinol and tocopherols in plasma (40 L) were ana-
lyzed by reversed phase HPLC as recently described
[40], with minor modiﬁcations. Retinol was quantiﬁed
by UV–vis (325 nm)  and tocopherols by ﬂuorescence
detection (excitation at 298 nm/emission at 328 nm). -
Tocopherol in liver, kidney, brain, and adipose tissues wasports 1 (2014) 1106–1114
determined  by HPLC with electrochemical detection as pre-
viously  described [14].
2.6.  Quantiﬁcation of ascorbic and uric acid in plasma
Plasma ascorbic and uric acid were analyzed by RP-HPLC
and  UV–vis detection (245 nm)  after reduction with tris-(2-
carboxyethyl)-phosphine (abcr GmbH & Co. KG, Karlsruhe,
Germany). Brieﬂy, 100 L of plasma was mixed with 25 L
of  20% (w/w) tris-(2-carboxyethyl)-phosphine and de-
proteinised with 75 L of 10% (w/w)  meta-phosphoric acid.
After  centrifugation (13,500 rpm, 4 ◦C), whole supernatant
was  transferred to an HPLC vial and 20 L was analyzed
on a Shimadzu Prominence HPLC. Separation of ascorbic
and  uric acid was  achieved using a 5 m analytical column
(Reprosil-Pur 120 C18 AQ 250 mm × 4.6 mm;  Trentec, Ger-
lingen,  Germany) set at 40 ◦C and a mobile phase consisting
of  0.05 M sodium phosphate buffer (pH 2.5) at a ﬂow rate
of  1 mL/min.
2.7.  Quantiﬁcation of total glutathione in whole blood,
and  glutathione and glutathione disulﬁde in tissues
Total glutathione in whole blood was analyzed after
reduction with 1,4-dithiothreit using 5,5′-dithiobis-2-
nitrobenzoic acid (Ellman). Brieﬂy, 100 L of whole blood
or  glutathione standard was ﬁrst reduced with 100 L 1,4-
dithiothreit (12.5 mol/L) and de-proteinised with 200 L
of  10% (w/v) trichloroacetic acid. Two  hundred L of the
supernatant was buffered with 100 L 2 M di-potassium
hydrogen phosphate and ﬁnally mixed with 50 L of Ell-
man  reagent (30 mmol/L dithiobis-2-nitrobenzoic acid in
0.5  M K2HPO4-buffer, pH 7.5); 20 L was  injected for anal-
ysis  on a Shimadzu Prominence HPLC using a Reprosil-Pur
120 C18 AQ column (5 m,  250 mm × 4.6 mm,  Trentec)
at 40 ◦C, a mobile phase consisting of 15% methanol and
0.05  M acetate buffer (pH 5, v/v) at 1 mL/min and UV–vis
detection at 326 nm.
Tissue samples were thawed on ice and ca. 200 mg
weighed into a 2 mL  test tube. One milliliter ice-cold 10%
PCA  solution (0.4 N perchloric acid and 100 nM EDTA,
both from Sigma) was added and samples sonicated thrice
for  15 s each. Homogenates were centrifuged (13,250 × g,
15  min, 4 ◦C) and 100 L supernatant transferred to an
HPLC vial, diluted with 100 L mobile phase, and 10 L
sample injected. Reduced glutathione (GSH) and glu-
tathione disulﬁde (GSSG) were separated on a Reprosil C18
column  (5 m,  250 mm × 3 mm;  Trentec-Analysentechnik,
Rutesheim, Germany) with 25 mM sodium dihydrogen-
phosphate; 1.4 mM 1-octanesulfonic acid, and 6% acetoni-
trile  (adjusted to pH 2.65) as mobile phase at a ﬂow rate of
0.6  mL/min. The HPLC system consisted of an AS-2057 Plus
autosampler, PU-2080 Plus pump, LG-2080-02 gradient
unit,  and a 3-line degasser (Jasco, Groß-Umstadt, Germany)
and  an ESA 5600A electrochemical detector equipped with
a  Boron Doped Diamond electrode model 5040 (Dionex,
Idstein, Germany) that was  set to +1500 mV  (vs. PD ref-
erence). Between injections, the electrode was cleaned by
applying  +1900 mV  for 30 s, and allowing a re-equilibration
time of 5 min. Peaks were recorded and integrated with
the  chromatographic software CoulArray 3.10 (ESA) and
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SH and GSSG were quantiﬁed against authentic external
tandards (Sigma).
.8.  Catalase activity
Catalase  (CAT) activities were determined according to
he  method of [6]. Brieﬂy, 60 L of diluted whole blood
see above) or CAT standard was added to 70 L working
eagent (phosphate buffer, pH 7.0, methanol, and hydrogen
eroxide; 3:3:1 by vol) and incubated for 10 min at room
emperature. Ninety L Purpald® (22.8 mmol) was  added,
he  sample incubated at room temperature for 20 min, and
he  absorbance read at 540 nm after addition of 30 L of
otassium periodate (65.2 mmol/L). A standard curve was
onstructed from dilutions of CAT standard and used to
alculate  the CAT activities of the samples. Results are
eported as U/mg protein.
.9.  Superoxide dismutase activity
Whole blood superoxide dismutase (SOD) activity was
etermined using a procedure modiﬁed from the original
ethod published by [16] and the modiﬁcations pub-
ished by [28]. Samples were prepared by diluting whole
lood  with H2O (1:20, v/v). Twenty microliter diluted sam-
le  was mixed with 20 L chloroform/ethanol (1:2, v/v)
olution. Thirty microliter of the resulting sample or of
OD  standards of known concentrations, respectively, were
ipetted  onto a 96-well plate and 250 L buffer (pre-
ared from 48 mL  of 24 mmol/L NaHCO3 and 15 mmol/L
aOH, with 1 mL  of 50 mmol/L xanthine in 100 mmol/L
aOH, and 1 mL  of 5 mmol/L iodonitrotetrazolium chlo-
ide  diluted in ethanol and water (0.11: 0.89)), and 20 L
f  0.15 U/mL xanthine oxidase in water were added to each
ell.  Absorbance was read at 505 nm at 37 ◦C in 1 min  inter-
als  for 30 min  on microplate reader (BioTekTM Synergy HT,
ioTekTM Instruments GmbH, Bad Friedrichshall, Deutsch-
and). The standard curve was generated from the linear
ate  of reaction SOD standards of known concentration and
OD  activity is reported as U/mg protein.
.10. Quantiﬁcation of ˛-cypermethrin in tissues
-Cypermethrin from liver, kidney, brain and adipose
issues were extracted and puriﬁed as previously described
10].  Brieﬂy, tissue samples (500 mg)  were homogenized
ith 5 g of sodium sulphate in a mortar, transferred to
crew  cap tubes, and well mixed with 5 mL  of hexane.
amples were extracted with 5 mL  acetonitrile and the
ixture vigorously shaken for 5 min. After centrifugation
15 min  at 2000 rpm), the whole lower acetonitrile phase
as  transferred and extracted using C18 solid phase extrac-
ion  cartridges (VertiPak, Thailand). Residues were eluted
ith  acetonitrile, evaporated (rotary evaporator at 35 ◦C,
00  mbar) to dryness, re-dissolved in 500 L ethyl acetate,
f  which 1 L was injected into and analyzed by GC-ECD
n  a HP 6890 with ChemStation B.04.02 (Agilent Technol-
gy,  USA) and the following operating conditions: HP-5
olumn (30 m × 0.32 mm × 0.25 m ﬁlm thickness, cross-
inked 5% PH ME  siloxane); injector in split-less mode
perated at 250 ◦C; oven temperature (column) at 100 ◦Cports 1 (2014) 1106–1114 1109
for  1 min, then changed to 250 ◦C with 25 ◦C/min ramp rate,
then  changed to 280 ◦C with 5 ◦C/min ramp rate, held at
280 ◦C for 5 min, and post run at 290 ◦C for 5 min. Oxy-
gen free nitrogen as make-up gas and helium as carrier
gas were from TIG, Bangkok. The limit of detection for -
cypermethrin was  0.1 g/kg tissue. Pooled liver samples
spiked with -cypermethrin (80 g/kg) and analyzed along
the  study samples gave intra-batch (n = 8) and inter-batch
(n = 10) coefﬁcients of variation of 8.5% and 13.7%, respec-
tively.
2.11.  Statistical analyses
All  statistical analyses were performed using SPSS soft-
ware  (SPSS Inc., Chicago, IL; Version 11.5) and GraphPad
Prism 5 for Mac  OS X (version 5.0c; GraphPad Software, Inc.,
La  Jolla, CA, USA). All data are given as mean with standard
deviation. Differences between groups were assessed by
means  of one-way ANOVA with Bonferroni’s multiple com-
parisons  test and considered signiﬁcant at P < 0.05.
3. Results and discussion
The  toxic and pro-oxidative effects of the pesti-
cide -cypermethrin have been investigated in rats
[3,9,11–13,23,27,30,32,38,41].  A major problem that lim-
its  the power of these studies to simulate the situation
in humans is the fact that they did not study continu-
ous low-level dietary exposure but a less realistic oral
intake of individual high doses of the pesticide once per
day.  We  thus designed the current experiment to investi-
gate  if the more realistic scenario of a continuous intake
of  small -cypermethrin doses spread-out over the day
[33],  amounting to a total daily intake comparable to the
doses  applied in previous studies [9,12,32], would lead to
impaired  antioxidant defence mechanisms and increased
lipid  peroxidation and if so, whether or not dietary cur-
cumin  might counteract these harmful effects. Curcumin
was chosen as test compound because of its antioxidant
activity in various model systems in addition to its reported
safety for human consumption, even at high doses (cur-
cumin  is generally recognized as safe by the US Food and
Drug  Administration), its widespread use as a colorant by
the  food industry and the high acceptance of this natural
plant compound by the consumers [21].
The daily -cypermethrin intake in the current study
was in the range of 20–35 mg/kg bodyweight (BW) and
thus  8–14% of the acute oral LD50 for adult rats, which is
250  mg/kg bodyweight [3]. Since rats consume their feed
in  approximately 14–18 meals over the course of one day
[31,42],  the individual doses were much lower and below
1%  LD50.
3.1.  Animal performance and hepatotoxicity
In our rats, feed intake and body weight were not
affected by -cypermethrin and were not signiﬁcantly
different between groups (Table 1), which concurs with
previous studies using individual high-dosage protocols
[11,12,27]. On the other hand, gastric intubation with
25  mg  cypermethrin per kg bodyweight (ca. 20–40% LD50;
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Table  2
Antioxidants, oxidative stress markers and biomarkers of liver damage in plasma and whole blood of rats fed control diets or identical diets supplemented
with  -cypermethrin (350 mg/kg), curcumin (1000 mg/kg), or a mixture of -cypermethrin and curcumin (350 and 1000 mg/kg, respectively) for seven
weeks.a
Control -Cypermethrin Curcumin -Cypermethrin +
Curcumin
P
Plasma
-Tocopherol (mol/L) 10.4 ± 1.3ac 7.2 ± 2.0b 12.2 ± 2.2c 8.6 ± 1.4ab <0.001
-Tocopherol (mol/L) 0.40 ± 0.06a 0.24 ± 0.12b 0.46 ± 0.11a 0.35 ± 0.09ab <0.001
Cholesterol (mmol/L) 3.1 ± 0.4 2.7 ± 0.9 3.3 ± 0.8 2.8 ± 0.5 0.233
Triacylglycerols (mmol/L) 1.1 ± 0.2 1.2 ± 0.6 1.4 ± 0.4 1.1 ± 0.4 0.264
Retinol (mol/L) 1.7 ± 0.2 1.8 ± 0.2 1.9 ± 0.4 2.0 ± 0.4 0.286
Ascorbic acid (mol/L) 72.1 ± 21.2 77.8 ± 37.5 77.5 ± 23.4 79.7 ± 34.4 0.948
Uric acid (mol/L) 84.2 ± 44.4 79.3 ± 33.7 89.9 ± 75.0 64.1 ± 17.4 0.655
Alanine transaminase (U/L) 45.6 ± 10.3a 58.1 ± 16.7ab 44.2 ± 9.6a 63.4 ± 7.3b <0.001
Alkaline phosphatase (U/L) 118.3 ± 22.7 113.1 ± 26.2 110.6 ± 26.9 126.4 ± 34.2 0.609
Aspartate transaminase (U/L) 122.8 ± 28.0 145.6 ± 29.9 133.6 ± 34.6 138.1 ± 26.7 0.396
Whole blood
Malondialdehyde (mol/L) 9.9 ± 1.7ab 11.3 ± 2.5a 9.4 ± 1.2ab 8.4 ± 1.1b 0.006
Total glutathione (mol/L) 1347 ± 81a 1246 ± 100ac 1093 ± 89b 1166 ± 121bc <0.001
1.5
2.3
iﬁcantlyCatalase activity (U/mg protein) 1.21 ± 0.46 
Superoxide dismutase activity (U/mg protein) 3.40 ± 1.90 
a Values within a row not sharing a common superscript letter are sign
see below for discussion) for 28 days resulted in reduced
bodyweight in male Wistar rats [32].
Consumption of -cypermethrin or curcumin alone did
not  affect the activities of the liver damage markers ALT,
ALP,  and AST in plasma in the present experiment (Table 2).
The  combined intake of -cypermethrin with curcumin
signiﬁcantly increased plasma ALT, but not ALP or AST
activities. However, because the activities of liver enzymes
remained within the reference ranges for healthy rats [26]
in  all groups, this statistically signiﬁcant increase is likely
without biological importance. In support of our data, even
high-dose feeding of 420 mg  cypermethrin/kg BW for 6
months  did not result in increases in serum liver enzymes
in  rats [38]. Even the increases in the activities of liver
enzymes in cypermethrin-exposed rats observed in some
studies  [23,32] remained within the reference ranges for
healthy  rats and are thus not indicative of hepatic injury.
Hence, it appears that statistically signiﬁcant effects on
liver  enzymes that remained within the boundaries of nor-
mal  biological variation have in the past been incorrectly
interpreted as pesticide-induced liver damage in some
studies.
3.2.  Accumulation of ˛-cypermethrin in tissues
-Cypermethrin was  only present in organs of animals
fed the pesticide, but not of control and curcumin only-fed
animals (Table 3). The fat-soluble -cypermethrin accumu-
lated  in adipose tissues at concentrations of up to 9.8 g/g
tissue,  whereas its contents (in descending order) were
much  lower in kidney, liver, and brain tissues. The simulta-
neous  ingestion of curcumin did not alter -cypermethrin
concentrations in any of these tissues (Table 3).
The higher concentrations of -cypermethrin residues
in adipose compared to brain and other tissues is in agree-
ment  with observations in male Sprague-Dawley rats given
a  single oral dose of a mixture of four pyrethroids (each
administered at 3 mg/kg bodyweight; including cyperme-
thrin) dissolved in glycerol formal. These authors proposed6 ± 0.91 1.56 ± 0.70 1.31 ± 0.57 0.564
8 ± 1.32 2.68 ± 1.31 4.02 ± 1.85 0.150
 different at P < 0.05.
that  the higher concentrations and longer persistence of
the  pesticides in adipose tissue may  be due to its slower
metabolism and lack of enzymes required for pyrethroid
hydrolysis [24]. Similarly, cypermethrin concentrations
in rats orally administered a single dose of a mixture
of six pyrethroids (of which 29% were cypermethrin)
in corn oil (total pyrethroids, 27.4 mg/kg bodyweight;
cypermethrin, 8 mg/kg bodyweight) were higher in adi-
pose  tissue (1.07 g/g), than in the brain (0.14 g/g) and
liver  (0.40 g/g) 2.5 h after dosing [39]. The higher -
cypermethrin concentrations in the adipose tissues of
our  animals are likely explained by the longer interven-
tion period (7 weeks vs. single oral dose in the above
studies) and the daily administration, which allowed tis-
sue  accumulation and the establishing of steady-state
concentrations. The concentrations in the single-dosing
experiments were likely determined at a point in time
when concentrations were increasing or decreasing and
may  thus not represent maximum tissue concentrations
and certainly not steady-state concentrations.
3.3. Redox status
Whole  blood MDA  concentrations were not signiﬁcantly
higher than in control rats after 7 weeks of low-level expo-
sure  to -cypermethrin, curcumin or -cypermethrin plus
curcumin. Simultaneous ingestion of -cypermethrin and
curcumin, however, signiﬁcantly reduced MDA  concen-
trations in comparison with exposure to -cypermethrin
alone (Table 2). -Cypermethrin-feeding, alone or in com-
bination with curcumin, did not alter MDA  concentrations
in the liver, kidney, brain or visceral and subcutaneous
adipose tissues (Table 3). Application of a single dose
of  125 mg/kg bodyweight cypermethrin by oral gavage
previously resulted in increased concentrations of MDA
in  plasma (by 54%), liver, and kidney in female Wistar
rats [9]. Other authors also reported increased markers
of  oxidative damage (MDA, thiobarbituric acid reactive
substances, or “oxidation index”) in erythrocytes, brains,
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Table 3
-Cypermethrin, malondialdehyde, -tocopherol, glutathione and glutathione disulﬁde in liver, kidney and adipose tissues of rats fed control diets or
identical  diets supplemented with -cypermethrin, curcumin, or a mixture of -cypermethrin and curcumin for seven weeks.a
Control -Cypermethrin Curcumin -Cypermethrin
+ Curcumin
P
-Cypermethrin (ng/g)
Liver  n.d. 53.2 ± 92.9 n.d. 84.2 ± 161.4 0.605
Kidney n.d. 523.9 ± 522.3 n.d.  701.5 ± 548.3 0.468
Brain  n.d. 17.5 ± 11.5 n.d.  10.3 ± 4.9 0.085
Visceral adipose tissue n.d. 9813 ± 2093 n.d. 8955 ± 2051 0.367
Subcutaneous adipose tissue n.d. 9288 ± 2325 n.d. 9252 ± 5329 0.985
Malondialdehyde (mol/g)
Liver 0.099 ± 0.066 0.105 ± 0.084 0.124 ± 0.105 0.217 ± 0.147 0.058
Kidney 0.047 ± 0.007 0.051 ± 0.008 0.045 ± 0.009 0.051 ± 0.008 0.235
Brain 0.005 ± 0.001 0.004 ± 0.005 0.005 ± 0.001 0.004 ± 0.001 0.125
Visceral adipose tissue 142.0 ± 48.9ab 202.0 ± 53.6a 131.1 ± 40.2b 175.6 ± 76.0ab 0.031
Subcutaneous adipose tissue 116.4 ± 39.2ab 125.4 ± 53.0ab 84.7 ± 43.4a 144.8 ± 37.7b 0.032
-Tocopherol (nmol/g)
Liver  5.19 ± 3.51 5.36 ± 3.48 8.35 ± 3.80 6.32 ± 3.30 0.186
Kidney 2.92 ± 0.35ab 2.40 ± 0.44a 3.27 ± 0.46b 2.68 ± 0.58a 0.001
Brain 1.84 ± 0.32a 2.89 ± 0.74b 2.23 ± 0.45ab 2.21 ± 0.77ab 0.005
Visceral adipose tissue 6.04 ± 0.96ab 5.52 ± 0.85a 7.30 ± 1.69b 6.05 ± 1.09ab 0.015
Subcutaneous adipose tissue 3.83 ± 1.10ab 2.92 ± 0.62a 4.23 ± 1.04b 3.41 ± 0.42ab 0.009
Glutathione
Liver (mol/g) 3.0 ± 0.5 2.9 ± 0.5 3.2 ± 0.4 3.4 ± 0.5 0.240
Kidney (nmol/g) 14.3 ± 4.4a 20.8 ± 11.5ab 19.4 ± 8.4ab 25.6 ± 6.5b 0.031
Visceral adipose tissue (nmol/g) 3.7 ± 1.5 4.8 ± 1.7 5.2 ± 2.4 5.1 ± 2.0 0.343
Subcutaneous adipose tissue (nmol/g) 6.4 ± 3.8 7.1 ± 2.9 4.8 ± 1.2 6.9 ± 4.0 0.419
Glutathione disulﬁde
Liver  (mol/g) 0.14 ± 0.05ab 0.23 ± 0.09a 0.12 ± 0.05b 0.20 ± 0.10ab 0.008
Kidney (nmol/g) 2.9 ± 0.9a 8.3 ± 2.4b 2.9 ± 1.5a 9.1 ± 2.4b <0.001
Visceral adipose tissue (nmol/g) 32.1 ± 6.5ab 37.1 ± 6.8a 29.0 ± 3.9b 36.7 ± 5.8a 0.014
37.8 ± 
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a Values within a row not sharing a common superscript letter are sign
ivers, or kidneys after single (≥100 mg/kg bodyweight) or
epeated  (≥12.5 mg/kg bodyweight for ≥28 days) gastric
ntubation of rats [11,13,23,27,41]. At low doses of 2.5 mg
ypermethrin per kg BW for 60 days, however, no lipid
eroxidation was observed in erythrocytes [27].
Whole blood concentrations of total glutathione
id not differ from control in -cypermethrin- and
-cypermethrin plus curcumin-fed rats, but were signiﬁ-
antly lower in only curcumin-fed rats (Table 2), although
he  extent of the effect was small. In liver and adipose
issues, reduced glutathione concentrations were simi-
ar  in all groups. Only in the kidney, the combination
f -cypermethrin plus curcumin signiﬁcantly increased
educed glutathione concentrations, whereas the pesticide
nd  the phytochemical alone, did only numerically increase
t  (Table 3). The oxidized form of glutathione, glutathione
isulﬁde, was signiﬁcantly higher in the kidney and subcu-
aneous  adipose tissue and numerically increased in the
iver  and visceral adipose tissue of -cypermethrin-fed
ats compared to control animals (Table 3). Ingestion of
urcumin did not affect glutathione disulﬁde concentra-
ions in these tissues and, consequently, its co-ingestion
ith -cypermethrin did not mitigate the -cypermethrin-
nduced increase in glutathione disulﬁde concentrations
Table 3). In comparison to control, -cypermethrin, cur-
umin,  or the combination of both did not alter SOD
ctivity. Compared to -cypermethrin-fed rats, the com-
ination of -cypermethrin and curcumin increased SOD
ctivity  (Table 2). CAT activity in whole blood was  not
ifferent between groups (Table 2). In the literature, the8.4b 26.4 ± 6.3ac 35.2 ± 9.4bc <0.001
 different at P < 0.05.
impact  of high doses of cypermethrin on the antioxidant
enzymes SOD and CAT in rats has been somewhat contra-
dictory. A single gastric dose of 125 mg/kg BW reduced the
activity  of both enzymes in plasma [9], whereas intuba-
tion  with 25 mg/kg BW for 60 days increased their activities
in  erythrocytes [27]. Gastric application of lower doses of
12.5  or 2.5 mg/kg BW for 60 days did not alter SOD or CAT
activities in erythrocytes [11,27].
Of the lipid- and water-soluble antioxidants mea-
sured in plasma, only - and -tocopherol (vitamin E)
were  signiﬁcantly reduced by exposure to -cypermethrin
(P < 0.001), while retinol, ascorbic acid and uric acid con-
centrations were similar in all groups (Table 2). Curcumin
consumption alone did not signiﬁcantly alter antioxidant
status compared to control, but numerically increased vita-
min  E concentrations and attenuated the decreasing effect
of  -cypermethrin in the combined -cypermethrin plus
curcumin group (Table 2). In a previous study, 4 week feed-
ing  of 4 g curcumin/kg diet to Sprague-Dawley rats only
numerically increased plasma, but signiﬁcantly increased
lung  vitamin E concentrations [18].
Since low-dose dietary exposure to -cypermethrin
did not induce overt oxidative stress in our animals, it
is  not surprising that curcumin did not reduce oxidative
stress markers in blood in the present study. A previous
study reporting protective effects of curcumin used cyper-
methrin (dissolved in oil) at a dose of 25 mg/kg BW/day
and thus produced signiﬁcant oxidant effects in liver, kid-
ney,  and brain [32]. The difference between their ﬁndings
and  ours can be partly explained by the use of younger
ology Re1112 S. Hongsibsong et al. / Toxic
animals, which weighed 199–227 g at the end of the exper-
iment  [32], which is even less than the weight of our
animals at the beginning (240–248 g) and half that at the
end  of our experiment (Table 1). Young rats are known
to  be more susceptible to the toxic effects of cyperme-
thrin. While the oral LD50 of adult rats is 250 mg/kg BW,
it  is signiﬁcantly lower for younger rats (21 days, 49; 16
days,  27; 8 days, 15 mg/kg BW)  [3]. Thus, the dose used
by  Sankar and colleagues (2010) exceeded the intended
10% LD50 and is more likely to have been in the range of
20–40% LD50 for rats of that particular age. Better absorp-
tion and higher maximum plasma concentrations of the
lipid-soluble insecticide when administered dissolved in
oil  may  have further contributed to the observed differ-
ences (see also Section 3.4 below). Furthermore, it cannot
be  ruled out, that the positive effects observed in their ani-
mals,  which were given curcumin 1 h prior to cypermethrin
intubation, may  have been confounded, as the used cur-
cumin  was diluted in gum arabic [32]. The oral toxicity
of  deltamethrin, another pyrethroid, was 100 times lower
when  dissolved in 10% gum arabic compared to oil or other
solvents [29]. In humans, the absorption of amoxicillin, an
antibiotic,  was  signiﬁcantly reduced when gum arabic was
ingested  simultaneously with or 2 h prior to the drug (AUC:
control,  21; simultaneous, 5; 2 h-prior, 11 Mg  h/L) [8]. Thus,
interactions of the gum arabic with cypermethrin absorp-
tion  cannot be ruled out and may, at least in part, explain
the  lower oxidative stress observed in rats given curcumin
prior to cypermethrin compared to those receiving only
cypermethrin.
3.4.  Matrix effects and bioavailability considerations
Overall, the above-mentioned studies used single or
repeated high-doses of cypermethrin dissolved in oil,
which  probably enhances the oral bioavailability of the
lipophilic insecticide and, thus, its toxicity, as previously
described for deltamethrin [29]. The increased uptake
of  cypermethrin from oil suspensions, particularly when
given  as a single dose, may  have resulted in much higher
maximum plasma and tissue concentrations of cyperme-
thrin than in our experiment and might explain the higher
level  of oxidative stress observed in blood and tissues of
these  rats. The animals in the current study, on the other
hand,  were exposed to low doses of -cypermethrin in
the  diet. Matrix effects may  have limited the absorption
of the insecticide and resulted in lower concentrations of
the  pesticide compared to rats exposed by gastric intu-
bation with oil suspensions and consequently resulted in
cypermethrin concentrations that did not sufﬁce to induce
oxidative stress. In agreement, dose-dependent increases
in  malondialdehyde have been reported in organs of ﬁsh
(Clarias  batrachus) exposed for 96 h to increasing doses
of  cypermethrin in the water [22] and in plasma of mice
given  5 or 10 mg  cypermethrin for 15, 45 or 60 days [19].
However, further experiments are warranted to test if the
food  or vehicle matrix may  signiﬁcantly alter cypermethrin
plasma and organ concentrations.
Overall, it appears likely that the potential pro-oxidative
effects of -cypermethrin are dose-dependent and that the
small  individual doses ingested in the present study andports 1 (2014) 1106–1114
the  thus likely lower maximum plasma and tissue con-
centrations of -cypermethrin may  explain the absence of
oxidative  stress in our animals.
The lack of biological activity of curcumin in the present
study may  be explained by its limited absorption, exten-
sive  metabolism and rapid elimination [21], which result
in  very low concentrations of free curcumin, if any at all,
and  the predominance of conjugated metabolites (mainly
glucuronic acid and sulphate conjugates) in the organ-
ism  [34]. Consequently, the parent compound, which
is  used in in vitro experiments and for which potent
antioxidant activities have been reported, is not the form
present in the organism and, importantly, the conjugates
are attached at the functional groups associated with its
antioxidant activity, rendering the metabolites much less
potent  antioxidants, if antioxidants at all (reviewed in
[21]).  The lack of any direct or indirect in vivo antioxidant
activity of native curcumin in the present study is in agree-
ment  with previous ﬁndings from different animal models
(e.g.  [5,35,36]). The low oral bioavailability of native cur-
cumin  has led to the development of novel strategies, for
example  the administration of curcumin micelles, that can
enhance  its absorption and plasma concentrations and thus
its  bioavailability in healthy humans by up to 185-fold [37].
Such  novel curcumin formulations with enhanced biologi-
cal  availability will be useful in future experiments aimed
at  studying the biological activities of this otherwise poorly
absorbed phytochemical.
4.  Conclusions
Even though high-dosage gastric intubation protocols
in  rats in the above cited studies resulted in statistically
signiﬁcant increases in oxidative stress and an inconsis-
tent modulation of antioxidant enzymes, the extent of
the  observed changes was  often small and their biological
relevance may  have been overrated. Using a more realis-
tic  scenario of continuous low-dose dietary exposure to
-cypermethrin, we did not observe liver damage or an
overt  induction of oxidative stress and impaired antioxi-
dant  defence in our rats. Our data suggest that previously
performed studies using single high-dosing protocols may
have  overestimated the induction of oxidative stress by and
the  hepatotoxic effects of cypermethrin, possibly due to
better  bioavailability of the insecticide from oil. Additional
studies are required to understand the impact of the food
matrix  on cypermethrin absorption kinetics, tissue distri-
bution,  and toxicity.
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